Skip to content
Politically.com Search all
Menu

2026 · 3rd Quarter (July 1 - Sep 30)

340B HEALTH

Filed by 340B HEALTH.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-11-02 06:26:10 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 15, 2026
Income
Not reported
Expenses
$330,000.00
Registrant
340B HEALTH
Filing UUID
86116d8d-d5f8-4865-9237-a95238e60523
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

PHA · Pharmacy

The SECURE 340B Act (H.R. 9599); The Tax-Exempt Hospital Transparency Act (H.R.9504); 340B PATIENTS Act (H.R. 4581/S.2372); The SUSTAIN 340B Act (S.5244); Senator Bill Cassidys 340B Discussion Draft bill 2027 OPPS Proposed Rule; Information Collection Request Title: 340B Rebate Model Pilot Program Application, Implementation, and Evaluation, OMB Number 0906-NEW; Manufacturer Demand for Access to in-House Pharmacy Claims Data; Lilly 340B Drug Pricing Denial; Notice Regarding 340B Rebate Model Pilot Program; Pending introduction of Reps. Bresnahan and Dingells two-year rebate model pilot ban legislation; FY27 Appropriations legislation.

Literal federal measure citations: H.R. 9599, H.R.9504, H.R. 4581, S.2372, S.5244

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.